• 1. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 5. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528

Introduction to N-(Chloroacetyl)2-amino-4-methylthiazole (CAS No. 50772-53-7)

N-(Chloroacetyl)2-amino-4-methylthiazole, identified by its Chemical Abstracts Service number CAS No. 50772-53-7, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic compound features a thiazole core, which is a crucial structural motif in many biologically active molecules. The presence of both chloroacetyl and amino functional groups makes it a versatile intermediate for synthesizing various pharmacologically relevant derivatives.

The compound's unique structure positions it as a valuable building block in drug discovery, particularly in the development of novel therapeutic agents targeting diverse diseases. Recent advancements in medicinal chemistry have highlighted the importance of thiazole derivatives in addressing challenges such as inflammation, infection, and metabolic disorders. The chloroacetyl moiety, in particular, is known for its reactivity, enabling the formation of amide bonds with amino acids or other nucleophiles, thereby facilitating the creation of complex molecular architectures.

In the context of modern drug design, N-(Chloroacetyl)2-amino-4-methylthiazole has garnered attention for its potential applications in the synthesis of kinase inhibitors and other small-molecule drugs. Kinases are enzymes that play a pivotal role in cell signaling pathways, and their dysregulation is often associated with cancer and inflammatory diseases. By leveraging the reactivity of the chloroacetyl group, researchers can develop inhibitors that selectively target specific kinases, thereby modulating pathological signaling networks.

Recent studies have demonstrated the utility of this compound in generating libraries of thiazole-based scaffolds for high-throughput screening (HTS). The combination of computational modeling and experimental validation has allowed researchers to identify promising candidates with enhanced binding affinity and selectivity. For instance, derivatives of N-(Chloroacetyl)2-amino-4-methylthiazole have shown promise in preclinical studies as inhibitors of Janus kinases (JAKs), which are implicated in autoimmune disorders such as rheumatoid arthritis.

The amino group on the thiazole ring further enhances the compound's versatility, allowing for conjugation with other functional groups or biomolecules. This feature is particularly useful in the development of prodrugs or targeted delivery systems. In particular, site-specific modifications enabled by this amino group have been explored in antibody-drug conjugates (ADCs), where N-(Chloroacetyl)2-amino-4-methylthiazole derivatives serve as linkers or warheads.

The synthesis of N-(Chloroacetyl)2-amino-4-methylthiazole involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advances in synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions and flow chemistry, have improved the efficiency and scalability of its production. These innovations not only reduce costs but also minimize waste, aligning with green chemistry principles.

Evaluation of the compound's pharmacokinetic properties is essential for its translation from laboratory research to clinical application. Studies have focused on its solubility, stability, and metabolic fate to optimize formulations for oral or parenteral administration. Additionally, toxicological assessments have been conducted to assess potential side effects and ensure safety margins for therapeutic use.

The role of computational chemistry in understanding the behavior of N-(Chloroacetyl)2-amino-4-methylthiazole cannot be overstated. Molecular dynamics simulations and quantum mechanical calculations have provided insights into its interactions with biological targets at an atomic level. These computational approaches complement experimental data by predicting binding modes and energetic landscapes, thereby accelerating the drug discovery process.

In conclusion, N-(Chloroacetyl)2-amino-4-methylthiazole represents a promising compound with broad applications in pharmaceutical research. Its unique structural features make it an excellent candidate for developing novel therapeutics targeting various diseases. As research continues to uncover new applications and synthetic strategies, this compound is poised to play a significant role in future medical advancements.

• 1217486-96-8(N-[4-(fluoromethyl)-2-thiazolyl]-Acetamide)
• 6081-87-4(2-Chloro-n-4-(4-methylphenyl)-1,3-thiazol-2-ylacetamide)
• 7460-59-5(N-[4-(chloromethyl)-1,3-thiazol-2-yl]acetamide)
• 908509-16-0(N-(4-tert-Butyl-1,3-thiazol-2-yl)-2-chloroacetamide)
• 1007650-66-9(2-hydroxy-N-(4-methyl-2-thiazolyl)-Acetamide)
• 726153-55-5(N-(4-{1,1'-biphenyl-4-yl}-1,3-thiazol-2-yl)-2-chloroacetamide)
• 7336-51-8(N-(4-Methylthiazol-2-yl)acetamide)
• 5039-16-7(2-Chloro-N-(4-phenyl-1,3-thiazol-2-yl)acetamide)
• 5448-49-7(2-chloro-N-(1,3-thiazol-2-yl)acetamide)
• 50772-54-8(2-chloro-N-(dimethyl-1,3-thiazol-2-yl)acetamide)